222 related articles for article (PubMed ID: 32046)
1. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.
Bogentoft C; Carlsson I; Ekenved G; Magnusson A
Eur J Clin Pharmacol; 1978 Dec; 14(5):351-5. PubMed ID: 32046
[TBL] [Abstract][Full Text] [Related]
2. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration.
Bogentoft C; Alpsten M; Ekenved G
J Pharm Pharmacol; 1984 May; 36(5):350-1. PubMed ID: 6145780
[TBL] [Abstract][Full Text] [Related]
3. Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated micro-granules.
Alpsten M; Bogentoft C; Ekenved G; Sölvell L
Eur J Clin Pharmacol; 1982; 22(1):57-61. PubMed ID: 7094976
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two enteric-coated acetylsalicylic acid preparations by monitoring steady-state levels of salicylic acid and its metabolites in plasma and urine.
Edgar B; Bogentoft C; Lagerström PO
Biopharm Drug Dispos; 1984; 5(3):251-60. PubMed ID: 6541512
[TBL] [Abstract][Full Text] [Related]
5. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
Montgomery PR; Sitar DS
Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three slow-release acetylsalicylic acid preparations in rheumatoid arthritis.
Martio J; Kahela P
Scand J Rheumatol; 1983; 12(3):305-9. PubMed ID: 6623020
[TBL] [Abstract][Full Text] [Related]
8. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.
Mojaverian P; Rocci ML; Conner DP; Abrams WB; Vlasses PH
Clin Pharmacol Ther; 1987 Jan; 41(1):11-7. PubMed ID: 3802700
[TBL] [Abstract][Full Text] [Related]
9. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
[TBL] [Abstract][Full Text] [Related]
10. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
Lui CY; Oberle R; Fleisher D; Amidon GL
J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
[TBL] [Abstract][Full Text] [Related]
11. Gastric retention of enteric-coated aspirin tablets in beagle dogs.
Nap RC; Breen DJ; Lam TJ; De Bruyne JJ
J Vet Pharmacol Ther; 1990 Jun; 13(2):148-53. PubMed ID: 2384905
[TBL] [Abstract][Full Text] [Related]
12. Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.
Kaniwa N; Aoyagi N; Ogata H; Ejima A; Motoyama H; Yasumi H
J Pharmacobiodyn; 1988 Aug; 11(8):571-5. PubMed ID: 3236215
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an enteric coated aspirin preparation.
Day RO; Paull PD; Champion GD; Graham GG
Aust N Z J Med; 1976 Feb; 6(1):45-50. PubMed ID: 1065299
[TBL] [Abstract][Full Text] [Related]
14. Platelet aggregation and plasma levels of acetylsalicylic acid in stroke patients on long-term treatment with an enteric-coated aspirin formulation.
Britton M; Melander A; Svensson J; Wåhlin-Boll E
Eur J Clin Pharmacol; 1984; 27(3):363-5. PubMed ID: 6510466
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function.
Ross-Lee LM; Elms MJ; Cham BE; Bochner F; Bunce IH; Eadie MJ
Eur J Clin Pharmacol; 1982; 23(6):545-51. PubMed ID: 7160424
[TBL] [Abstract][Full Text] [Related]
16. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
17. Interaction of omeprazole with enteric-coated salicylate tablets.
Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
[TBL] [Abstract][Full Text] [Related]
18. [Study of salicylemia after absorption of coated acetylsalicylic acid; comparison with the results obtained with classical preparations].
Delbarre F; Tiffeneau JM; Brouilhet H; Delassue H
Sem Ther; 1965 Dec; 41(10):578-81. PubMed ID: 5878068
[No Abstract] [Full Text] [Related]
19. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 4th Part: Influence of the enteric polymer dissolution pH on the "in vivo" absorption of aspirin from coated tablets (author's transl)].
Delporte JP; Jaminet F
J Pharm Belg; 1976; 31(3):263-76. PubMed ID: 8603
[No Abstract] [Full Text] [Related]
20. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]